Rating History for MAP Pharmaceuticals (MAPP) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for MAPP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/1/2013 N/A Downgrade Neutral
(Outperform)		 N/A
(N/A)		 25.00
(27.25)		 9% Details